Systemic Corticosteroid Use for COVID-19 in US Outpatient Settings From April 2020 to August 2021

This study uses 2 large US health care claims databases (Medicare fee-for-service and the US Food and Drug Administration’s Sentinel System) to examine systemic

Related Keywords

United Kingdom ,Hampshire ,Sandia Akhtar ,Efe Eworuke ,Jeffreya Kelman ,Austin Cosgrove ,Kristin Walter ,Judith Maro ,Davidj Graham ,Ghana Lee ,Noelle Cocoros ,Jodyw Zylke ,Mariec Bradley ,Hai Lyu ,Dal Pan ,Kushalb Naik ,Kaiser Permanente Northwest Center ,Ms Department Of Population Medicine ,Veterans Health Administration ,Centers For Drug Evaluation ,Aetna ,Us Department Of Health ,Sentinel System Initiative ,Health Clinical Trial Services ,Centers For Medicare Medicaid Services ,Office Of Surveillance ,National Institutes Of Health ,Human Services ,Drug Administration ,Harvard Medical School ,Humana Inc ,Healthpartners Institute ,Institute Inc ,Randomised Evaluation ,National Institutes ,Sentinel System ,Sentinel Rapid ,Deputy Editor ,Drug Evaluation ,Hampshire Ave ,Silver Spring ,Interest Disclosures ,Medicaid Services ,Population Medicine ,Clinical Trial Services ,Kaiser Permanente Northwest ,